Canine Plasma

$0.00

Canine Plasma – Research-Grade Plasma for Veterinary, Toxicology, and Immunological Applications

Canine Plasma (Cat. #: ABP2020.01) is a high-quality, K2 EDTA-preserved plasma matrix collected from healthy, laboratory-conditioned Beagle dogs. This biologically rich plasma retains native blood proteins, clotting factors, and electrolytes, making it a critical reagent for veterinary diagnostics, coagulation research, immunoassays, and nutritional and toxicology studies.

Sourced from fasted, ketamine-free adult canines screened by licensed veterinarians, this material is aseptically collected using venipuncture and frozen at −20 °C or colder to maintain analyte integrity. Each lot is processed under stringent controls to ensure consistent quality for regulated and exploratory applications. Suitable for use in research and the manufacture of non-injectable products.

Key Features

  • Derived from healthy, ketamine-free, laboratory-conditioned Beagles

  • Contains native coagulation proteins and blood analytes

  • Collected with K2 EDTA; no preservatives added

  • Frozen at −20 °C or colder to preserve stability

  • Available in lot-specific volumes

  • For research use or non-injectable manufacturing only

  • Not viral tested – handle using appropriate biosafety protocols

Applications

  • Veterinary diagnostic and coagulation assay development

  • Immunoassay and biomarker analysis

  • Preclinical pharmacology and toxicology research

  • Nutritional and metabolic profiling in canine models

  • Protein binding, plasma matrix calibration, and QC studies

  • Comparative physiology and translational research

Canine Plasma – Research-Grade Plasma for Veterinary, Toxicology, and Immunological Applications

Canine Plasma (Cat. #: ABP2020.01) is a high-quality, K2 EDTA-preserved plasma matrix collected from healthy, laboratory-conditioned Beagle dogs. This biologically rich plasma retains native blood proteins, clotting factors, and electrolytes, making it a critical reagent for veterinary diagnostics, coagulation research, immunoassays, and nutritional and toxicology studies.

Sourced from fasted, ketamine-free adult canines screened by licensed veterinarians, this material is aseptically collected using venipuncture and frozen at −20 °C or colder to maintain analyte integrity. Each lot is processed under stringent controls to ensure consistent quality for regulated and exploratory applications. Suitable for use in research and the manufacture of non-injectable products.

Key Features

  • Derived from healthy, ketamine-free, laboratory-conditioned Beagles

  • Contains native coagulation proteins and blood analytes

  • Collected with K2 EDTA; no preservatives added

  • Frozen at −20 °C or colder to preserve stability

  • Available in lot-specific volumes

  • For research use or non-injectable manufacturing only

  • Not viral tested – handle using appropriate biosafety protocols

Applications

  • Veterinary diagnostic and coagulation assay development

  • Immunoassay and biomarker analysis

  • Preclinical pharmacology and toxicology research

  • Nutritional and metabolic profiling in canine models

  • Protein binding, plasma matrix calibration, and QC studies

  • Comparative physiology and translational research

 
Canine Plasma

Intended Use and Customer Responsibility

Golden West BioSolutions, LLC products are specifically designed for research and the manufacturing of non-injectable products. It is the customer's responsibility to handle these products safely and responsibly. Golden West BioSolutions, LLC is not liable for any injuries stemming from the use or handling of its products. All disposal procedures must align with federal and state regulations.

Quality Assurance Disclaimer

Golden West BioSolutions, LLC does not warrant the performance of their products in specific applications. Customers are responsible for determining the suitability and qualification of Golden West BioSolution products for their intended use. Given the natural variation in biological materials, Golden West BioSolutions, LLC also recommends consideration of lot-to-lot evaluation